SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Smithkline Beecham (SBH) -- Ignore unavailable to you. Want to Upgrade?

To: kumar L chalasani who wrote (16)2/2/1998 6:12:00 AM
From: Henry Niman  Respond to of 61
 
I have added CNBC's initial report (GLX opened up 27%, SBH up 19%, and FTSE100 up 135 points) and Kevin Wilson interview (top 10 US Drug makers need tyo re-evaluate). Analysis by WSJ and NY times story has also been linked to
home.att.net



To: kumar L chalasani who wrote (16)2/7/1998 2:44:00 PM
From: Henry Niman  Read Replies (1) | Respond to of 61
 
Next week's Barron's suggests that the GLX/SBH merger is NOT made in heaven. I
have linked the relevant excerpt to the ALLIANCES section of
home.att.net under the SBH and GLX tables (both say
"Made in Heaven NOT").


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News